Jonathan Ponciano
As seen in:
The Motley Fool (U.S.),
Forbes,
MSN,
UOL,
Aol,
Yahoo Finance,
Investopedia,
Flipboard,
Nasdaq,
Forbes México,
The Charlotte Observer
and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Jonathan Ponciano
A Vaxcyte Executive Just Cashed Options Struck at $5.35. Here's What Long-Term Investors Should Know
Vaxcyte's primary target markets include healthcare systems, public health agencies, and pharmaceutical partners seeking next-generation vaccines to address unmet medical needs in infectious disease prevention, particularly in immunocompromised and elderly populations.
Vaxcyte's CEO Parted With Shares for Taxes. Here's What Long-Term Investors Should Know About the Firm
The disposition of 6,289 shares at $61.20 per share represented a transaction value of about $384,900. • The transaction involved shares equal to 0.87% of the total equity stake held before the filing, resulting in a minor reduction of the overall position. • The shares were withheld by the issuer to satisfy tax obligations related to the vesting of restricted stock units.
Retirement Planning for People Without Kids: Preparing for Long-Term Care and Estate Management Original
Key Takeaways Child-free retirees often enjoy more flexibility but must proactively plan for long-term care and estate decisions. Without heirs, the focus shifts from legacy building to safe spending, optimal risk taking, and tax-smart asset drawdowns. Naming trustworthy proxies and setting up proper beneficiary structures is particularly important when kids aren’t in the picture. Not having kids might mean fewer financial obligations, but it doesn’t automatically make retirement planning easier.
A Trading Plan Adopted in March Just Moved Block Shares at $80.80. Here's What Changed at the Company in Between
Amrita Ahuja, the CFO and COO of Block, Inc. (NYSE:XYZ), disclosed the disposition of 31,013 shares on August 20 and August 21, as detailed in a recent SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($80.80); post-transaction value based on the August 24 market close ($81.38). • What were the mechanics behind the reported share disposition?
Reddit's COO Reported a Disposition and Still Holds More Than 1 Million Shares. Here's What to Know
About Your Privacy We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent and legitimate interest. You may exercise your right to consent or object to a legitimate interest, based on a specific purpose below or at a partner level in the link under each purpose.
Reddit's Steve Huffman Filed a Form 4 Right as the Index Pop Faded. Here's What Long-Term Investors Should Know
Steve Ladd Huffman, the CEO and president of Reddit, Inc. (NYSE:RDDT), disposed of 40,336 shares of Class A Common Stock on August 20, according to a recent SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($151.71); post-transaction value based on the August 20 market close ($150.31). • What was the nature of this transaction?
A Peloton Insider Just Parted With Nearly $500,000 in Stock. Here's What Long-Term Investors Should Know
Nick V. Caldwell, chief product officer of Peloton Interactive, Inc. (NASDAQ:PTON), disposed of 87,159 shares of Class A Common Stock on August 17, according to a recent SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($5.63); post-transaction value based on the August 17 market close ($5.29). • What was the nature of this share disposition?
What to Know About the CFO of Lumentum's Latest Insider Transaction Filing
Ali Wajid, EVP and chief financial officer of Lumentum Holdings Inc. , reported the disposal of 10,728 shares of the company on August 19 and August 21, according to an SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($851.79); post-transaction value based on the August 21 market close ($866.71). • What was the nature of this equity disposition?
Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run
Axsome Therapeutics (AXSM -0.13%), a biotech company, has performed fairly well this year. The company's shares are up 16% versus the S&P 500's 11%. Could the stock rise even higher? Wall Street certainly thinks so. Axsome Therapeutics' average price target (according to Yahoo! Finance) of $285.42 implies about a 37% upside from its current level. Let's find out why Wall Street is bullish on the stock and whether it's time to buy it. Image source: The Motley Fool.
Dropbox's CTO Is Selling on a Plan He Set 15 Months Ago. Here's What to Know
Dropbox serves a diverse customer base spanning individual consumers, small and medium-sized businesses, and large enterprises across the United States and international markets, with particular strength in knowledge worker and professional services segments.
What to Know About the Latest Sale From Cardinal Health's Chief Accounting Officer
Mary C. Scherer, the chief accounting officer of the firm, sold 2,302 shares of Cardinal Health, Inc. (NYSE:CAH) on August 19, according to an SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($237.39); post-transaction value based on the August 19 market close ($234.85). • What is the current scale of equity ownership for the Chief Accounting Officer following this sale?
Cardinal Health's Medical Segment Boss Sold $8 Million in Stock. Here's What to Know
Key Points The disposition of 35,000 shares on August 18 generated a total transaction value of $8.3 million. The transaction involved exclusively directly held shares, with the insider reporting no indirect ownership in this filing. The divestment follows a one-year total return of 57% for the stock as of the transaction date. 10 stocks we like better than Cardinal Health › Stephen M. Mason, CEO of the firm's GMPD Segment, sold 35,000 shares of Cardinal Health, Inc.
Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened
Key Points Deborah Weitzman sold 7,354 shares for approximately $1.7 million on August 18. The entire disposition was executed through direct ownership, with no indirect holdings reported in the filing. This activity occurred following a 57% one-year stock price return as of the August 18 transaction date. 10 stocks we like better than Cardinal Health › Deborah Weitzman, CEO of the PSS Segment, reported a sale of 7,354 shares of Cardinal Health, Inc. (NYSE:CAH) in a recent SEC Form 4 filing.
The CIO of Cardinal Health Parted With 11,650 Shares. Here's Whether It Matters for Long-Term Investors
Key Points The disposition involved 11,650 shares at a weighted average price of $235.72, totaling approximately $2.7 million. Greene executed the sale directly and maintains no indirect equity holdings through trusts or other legal entities. The activity occurred following a period of appreciation for the company, with shares reflecting a 57% one-year return as of the August 18 transaction date. 10 stocks we like better than Cardinal Health › Michelle D.
Cardinal Health's Medical Segment Boss Sold $8 Million in Stock. Here's What to Know
Stephen M. Mason, CEO of the firm's GMPD Segment, sold 35,000 shares of Cardinal Health, Inc. (NYSE:CAH) on August 18, according to an SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($236.40); post-transaction value based on the August 18 market close ($234.98). • What is the scale of this transaction relative to the insider's remaining position? The sale of 35,000 shares represents a majority of the insider's position, leaving a direct holding of 18,061 shares.
Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened
Deborah Weitzman, CEO of the PSS Segment, reported a sale of 7,354 shares of Cardinal Health, Inc. (NYSE:CAH) in a recent SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($235.45); post-transaction value based on the August 18 market close ($234.98). • How does this liquidation impact the insider's equity position?
The CIO of Cardinal Health Parted With 11,650 Shares. Here's Whether It Matters for Long-Term Investors
Michelle D. Greene, chief information officer of Cardinal Health, Inc. (NYSE:CAH), sold 11,650 shares of common stock on August 18, according to a recent SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($235.72); post-transaction value based on the August 18 market close ($234.98). • How was the price execution structured for this disposition?
Cardinal Health's Legal Chief Just Filed an Insider Transaction. Here's What to Know
Key Points The sale realized $7.0 million based on a weighted average execution price. The transaction represents a 47% reduction in Mayer direct equity holdings. Mayer maintains a direct position of 33,076 shares following the disposition. 10 stocks we like better than Cardinal Health › Jessica L. Mayer, chief legal officer of Cardinal Health, Inc. (NYSE:CAH), sold 29,436 shares of common stock at $236.19 per share on August 18, according to an SEC Form 4 filing.
Cardinal Health's Legal Chief Just Filed an Insider Transaction. Here's What to Know
Jessica L. Mayer, chief legal officer of Cardinal Health, Inc. (NYSE:CAH), sold 29,436 shares of common stock at $236.19 per share on August 18, according to an SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($236.19); post-transaction value based on the August 18 market close ($234.98). • What were the execution details of the transaction? The shares were sold in multiple transactions at price intervals ranging from $234.07 to $237.67 per share.
Cardinal Health's CEO Moved 124,529 Shares in Two Days. Here's What Long-Term Investors Should Know
Key Points Jason M. Hollar disposed of 125,000 shares at a weighted average price of $235.89 per share across two trading sessions. The divestment involved only directly held shares; Hollar retains nearly 191,000 shares valued at $44.76 million following the sale. The liquidity event occurred following a 58% one-year return for the stock as of the August 19 market close. 10 stocks we like better than Cardinal Health › Chief Executive Officer Jason M.
Cardinal Health's CEO Moved 124,529 Shares in Two Days. Here's What Long-Term Investors Should Know
Chief Executive Officer Jason M. Hollar sold nearly 125,000 shares of Cardinal Health, Inc. (NYSE:CAH) for $29.4 million on August 18 and August 19, according to an SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($235.89); post-transaction value based on the August 19 market close ($234.85). • What is the current equity stake of the Chief Executive Officer following this sale?
A Synaptics Insider Filing Lands as a $7.8 Billion Combined Company Takes Shape
Key Points The transactions involved 1,409 shares with a total value of approximately $153,000 based on weighted average execution prices. The disposal included 972 shares withheld for tax obligations and 437 shares sold under a Rule 10b5-1 trading plan. The activity followed the vesting of 4,711 shares on August 17, representing routine portfolio management following an equity award.
Synaptics' CEO Sold Stock After a 120,000-Share Vest. Here's What to Know.
Key Points The disposition involved 17,578 shares at a weighted average price of $109.91 per share, representing about $1.9 million in total value. The activity consisted of 15,302 shares withheld for tax obligations and 2,276 shares sold under a Rule 10b5-1 trading plan established on September 4, 2025. This routine liquidity event follows a vesting of 120,000 shares and reflects standard equity compensation management. 10 stocks we like better than Synaptics › President and CEO Rahul G.
Synaptics' CFO Disposed of Stock as an 88%-12% OnSemi Ownership Split Takes Shape. Here's What to Know
Key Points Ken Rizvi disposed of 17,251 shares on August 17, representing a total transaction value of $1.9 million. The activity was entirely non-discretionary and was conducted to satisfy tax withholding obligations related to the settlement of various equity awards. Following the transaction, the insider retains about 134,000 shares of common stock held directly.
Synaptics' CEO Sold Stock After a 120,000-Share Vest. Here's What to Know.
President and CEO Rahul G. Patel reported the sale of 17,578 shares of Synaptics Incorporated (NASDAQ:SYNA) for a total value of about $1.9 million, according to an SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($109.91); post-transaction value based on the August 19 market close. • Why was this transaction executed?
Synaptics' CFO Disposed of Stock as an 88%-12% OnSemi Ownership Split Takes Shape. Here's What to Know
Ken Rizvi, the chief financial officer of Synaptics Incorporated (NASDAQ:SYNA), reported the disposition of 17,251 shares on August 17, according to an SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($110.58); post-transaction value based on the August 17 market close ($110.58). • What was the motivation behind this equity disposition?
A Synaptics Insider Filing Lands as a $7.8 Billion Combined Company Takes Shape
The company operates a fabless semiconductor business model, designing specialized chips for consumer electronics, computing devices, and mobile applications while leveraging third-party foundries for manufacturing and distribution through OEM partners and system integrators. What is the broader insider ownership profile following this transaction? Following this disposal, collective insider ownership in the semiconductor firm is approximately 0.04% of the outstanding shares.
Why Synaptics' Product Chief Filing Connects to Core IoT Sales Growing 24%
Vikram Gupta, chief product officer at Synaptics Incorporated (NASDAQ:SYNA), disclosed the disposition of 21,982 shares of common stock on August 17 and August 18, according to a recent SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($109.23); post-transaction value based on the August 18 market close ($104.83). • What was the primary driver of the equity disposition?
Synaptics' Chief Strategy Officer Disposed of Stock as 45,910 Shares Vested. Here's What to Know.
Satish Ganesan, chief strategy officer at Synaptics Incorporated (NASDAQ:SYNA), disposed of 15,954 shares on August 17 in a non-discretionary transaction valued at $1.8 million, according to an SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($110.58); post-transaction value based on the August 17 market close ($110.58). • What necessitated this automated share disposition?
Synaptics' Top Lawyer Sold Stock as a $7 Billion Merger Moves Toward Closing. Here's What to Know
The company operates a fabless semiconductor business model, designing specialized chips for user interface and connectivity applications while outsourcing manufacturing to third-party foundries, thereby optimizing capital efficiency and enabling rapid product iteration.
Synaptics' Top Lawyer Sold Stock as a $7 Billion Merger Moves Toward Closing. Here's What to Know
Key Points The disposition of 20,274 shares was valued at about $2.2 million based on weighted average execution prices on August 17 and August 18. The activity included 14,218 shares withheld for tax obligations and 6,056 shares sold under a Rule 10b5-1 trading plan established in September 2025. The move follows a vesting of 41,734 shares and occurs as the stock has generated a roughly 50% return as of August 18.
Why Synaptics' Product Chief Filing Connects to Core IoT Sales Growing 24%
Key Points The total transaction value reached $2.4 million based on a weighted average execution price of $109.23 per share. The filing details 17,705 shares withheld for tax obligations and 4,277 shares sold via a pre-arranged Rule 10b5-1 trading plan. Vikram Gupta continues to hold a direct position of about 103,000 shares with a market value of $10.85 million as of the August 18 market close.
A QuantumScape Insider Filing Involves $197,000 of Shares. Here's How It Ties to the Company's Next Platform
Key Points The executive disposed of 34,304 shares at $5.74 per share on August 18 for a total value of about $196,905. The transaction reduced Singh's direct equity position by just 2%. The sale was a non-discretionary transaction executed solely to satisfy tax withholding obligations related to the vesting of restricted stock units. Singh maintains a direct position of roughly 1.7 million shares, representing a 0.3% ownership interest in the battery technology company.
Upstart's CFO Sold Stock as the Company Returned to Profit. Here's What to Know
Andrea Blankmeyer, the chief financial officer of Upstart Holdings, Inc. (NASDAQ:UPST), sold 10,175 shares in a non-discretionary transaction on August 17 and August 19, according to an SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($29.35); post-transaction value based on the August 19 market close ($30.60). • What was the primary driver for this share disposition?
Here's What to Know About Coach CEO Todd Kahn's Latest Insider Transaction
Todd Kahn, the CEO and brand president of Coach, disposed of 1,955 shares of Tapestry, Inc. (NYSE:TPR) at $131.72 per share on August 19, according to an SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average sale price ($131.72); post-transaction value based on the August 19 market close ($131.72). • What was the specific context of this disposition?
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Jonathan
Contact Jonathan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack